BSD Medical Signs Distribution Agreement with and Ships MicroThermX® Microwave Ablation Products to Active Medical Inc. Business Wire SALT LAKE CITY -- December 11, 2013 BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that the Company has signed an agreement with Active Medical, Inc. (Active) for the sales and distribution of the MicroThermX Microwave Ablation (MicroThermX) line of products. Pursuant to the agreement, BSD recently commenced shipment of MicroThermX systems and synchronous phased array disposable antennas to Active. Active has an extensive 26-year history selling interventional radiology and surgical devices produced by some of the leading medical companies in the U.S. and has successful long-term relationships with these companies. Active has 17 sales personnel specializing in selling innovative surgical and interventional radiology products. Based in Harrisburg, Pennsylvania, Active has the rights to market the MicroThermX^® line of products in Delaware, Maryland, North Carolina, Pennsylvania, South Carolina, Virginia and West Virginia. These states have a combined population of approximately 53 million people. The Active sales team will work in close collaboration with BSD sales management and our direct sales representatives to penetrate this significant U.S. market opportunity. “BSD’s partnership with Active Medical is very synergistic as both companies have products that target the interventional radiology and surgical markets,” said Brian Ferrand, BSD Vice President of Domestic Sales. “Active already has the relationships with key interventional radiologists and administrators that are important for MicroThermX to be successful in the hospital environment. We expect Active will make a strong contribution toward expanding our MicroThermX user base in the Eastern U.S. and increasing domestic revenue.” About the MicroThermX ^ Microwave Ablation System The MicroThermX Microwave Ablation System is a compact, mobile, state-of-the-art, proprietary system that includes a microwave generator, single-patient-use disposable antennas, and a thermistor-based temperature monitoring system. The innovative design of the MicroThermX ^ is the first of its kind that allows delivery of higher power levels using a single generator. The MicroThermX ^ utilizes innovative synchronous phased array technology that was developed and patented by BSD to provide larger and more uniform zones of ablation during a single procedure. The MicroThermX product line includes an innovative, high-end disposable that is used in each ablation treatment, and provides ongoing revenue streams for BSD. The soft tissue ablation world market potential is estimated to exceed $2.3 billion. The U.S. Food and Drug Administration (FDA) has granted the Company a 510(k) clearance to market the MicroThermX for ablation of soft tissue. BSD has also received CE Marking for the MicroThermX System, which allows BSD to market the MicroThermX ^ system in Europe. CE marking is also recognized in many countries outside of the EU, providing BSD the ability to market the MicroThermX ^ to a number of international markets. About BSD Medical Corporation BSD Medical Corporation develops, manufactures, markets and services systems to treat cancer and benign diseases using heat therapy delivered using focused microwave energy and radiofrequency (RF). BSD’s microwave ablation system has been developed as a stand-alone therapy to ablate and destroy soft tissue. BSD’s hyperthermia cancer treatment systems, which have been in use for several years in the United States, Europe and Asia, are used to treat certain tumors with heat (hyperthermia) while increasing the effectiveness of other therapies such as radiation therapy. The Company has developed extensive intellectual property, multiple products in the market and well established distribution in the United States, Europe and Asia. Certain of the Company’s products have received regulatory approvals in the United States, Europe and China. For further information visit BSD Medical's website at www.BSDMedical.com. Statements contained in this press release that are not historical facts are forward-looking statements, as defined in the Private Securities Litigation Reform Act of 1995. All forward-looking statements are subject to risks and uncertainties detailed in the Company's filings with the Securities and Exchange Commission, including the market demand for our MicroThermX products and the regulatory requirements we face. These forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update such statements to reflect events or circumstances arising after such date, except as required by law. Contact: BSD Medical Corporation William Barth, 801-972-5555 fax: 801-972-5930 firstname.lastname@example.org
BSD Medical Signs Distribution Agreement with and Ships MicroThermX® Microwave Ablation Products to Active Medical Inc.